NUSEP HOLDINGS LTD (NSP)

NuSep is a Life Science company that provides innovative separations technology to redefine biological markets. NuSeps patented PrIME technology is currently used to manufacture human blood plasma products in mini-plasma mills thus redefiniting global blood fractionation market. PrIME is also being used to establish a new way of separating human sperm for the IVF market.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
NSP	0.059	0%	0.053	0.059	0.000	0.000	0.000	0

NUSEP HOLDINGS LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	NSP
Securities	ASX Code, Security Description ------------------------------ NSP, Ordinary Fully Paid
Official Listing Date	14 May, 2007
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.nusep.com
Registered Office Address	324 Burns Bay Road, LANE COVE, NSW, AUSTRALIA, 2066
Head Office Telephone	(02) 84157300
Head Office Fax	(02) 84157399
Share Registry	BOARDROOM PTY LIMITED LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	(02) 9290 9600

Directors / Senior Management
Mr John Manusu (Non Exec. Chairman, Director) Dr Chenicheri Hariharan Nair (Deputy Chairman, Non Exec. Director) Mr Prakash Patel (Managing Director, CFO) Mr Clifford Eu (Non Exec. Director) Mr Andrew Goodall (Non Exec. Director)

Company Secretary	Mr Tom Rowe
Principal Activities	NuSep is a Life Science company that provides innovative separations technology to redefine biological markets. NuSeps patented PrIME technology is currently used to manufacture human blood plasma products in mini-plasma mills thus redefiniting global blood fractionation market. PrIME is also being used to establish a new way of separating human sperm for the IVF market.

NUSEP HOLDINGS LTD announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
21/05/2013		NuSep Appoints KPMG as Company Auditor	2	PDF
20/05/2013		NuSep Update	4	PDF
15/05/2013		PrIME Update	2	PDF
08/05/2013		NSP Cleansing Notice	1	PDF
01/05/2013		Resignation of Auditor	2	PDF
01/05/2013		NuSep Singapore PrIME Fundraising and Appendix 3B	11	PDF
15/03/2013		Divestiture of non-core ProteoIQ software	2	PDF
01/03/2013		Reinstatement to Official Quotation	1	PDF
01/03/2013		NuSep Half Year Report & Accounts	27	PDF
01/03/2013		Suspension from Official Quotation	1	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
15 May 2013	0.059	18%	0.059	0.058	150,000
14 May 2013	0.050	-16.67%	0.052	0.050	110,000
08 May 2013	0.060	-3.23%	0.060	0.060	20,917
01 May 2013	0.062	10.71%	0.062	0.060	105,441
29 Apr 2013	0.056	-6.67%	0.056	0.056	65,500

* Volume of shares shown represents only those shares traded on ASX.

NUSEP HOLDINGS LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security NSP. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security NSP

Warrants & Structured Products

No warrants & Structured Products are available over the security NSP

ASX CFDs

No Contracts For Differences are available over the security NSP

MyASX: Login | Sign up